Quantifying the risks and benefits of efavirenz use in HIV‐infected women of childbearing age in the USA

Objectives The aim of the study was to quantify the benefits (life expectancy gains) and risks (efavirenz‐related teratogenicity) associated with using efavirenz in HIV‐infected women of childbearing age in the USA. Methods We used data from the Women's Interagency HIV Study in an HIV disease s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	HIV medicine 2011-02, Vol.12 (2), p.97-108
Hauptverfasser:	Hsu, HE, Rydzak, CE, Cotich, KL, Wang, B, Sax, PE, Losina, E, Freedberg, KA, Goldie, SJ, Lu, Z, Walensky, RP
Format:	Artikel
Sprache:	eng
Schlagworte:	Abnormalities, Drug-Induced - epidemiology Adult Alkynes Anti-HIV Agents - adverse effects Benzoxazines - adverse effects Cyclopropanes efavirenz Female HIV Infections - drug therapy HIV Infections - mortality HIV/AIDS Humans Life Expectancy Pregnancy Pregnancy Complications, Infectious - drug therapy Pregnancy Outcome Risk Assessment Risk Factors teratogenicity Teratogens - toxicity United States - epidemiology women
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!